YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson is predicting $2.5 billion in sales this year for its COVID-19 vaccine.
The company expects to produce up to 600 million doses of the one-shot vaccine this year. The previous goal was 1 billion shots.
The shot has faced production issues at a Baltimore plant run by J&J subcontractor Emergent BioSolutions Inc. Production was shut down after the U.S. Food and Drug Administration found sanitary problems and bad manufacturing practices, according to Reuters.
Read more from Reuters.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects